STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide

Anti-androgen drugs are the standard pharmacological therapies for treatment of non-metastatic prostate cancer (PCa). However, the response of PCa cells may depend on the anti-androgen used and often patients become resistant to treatment. Thus, studying how the anti-androgen drugs affect oncogenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Sandra M., Nascimento, Daniel, Cardoso, Ana Margarida, Passarinha, Luís, Socorro, Sílvia, Maia, Cláudio J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879076/
https://www.ncbi.nlm.nih.gov/pubmed/36660947
http://dx.doi.org/10.3892/mmr.2023.12939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879076/
https://www.ncbi.nlm.nih.gov/pubmed/36660947
http://dx.doi.org/10.3892/mmr.2023.12939

Ejemplares similares